SCOLR Pharma Inc. (SCLR)
-OTC Markets 0.00 
0.00(66.67%) May 24, 3:31PM EDT
| Prev Close: | 0.00 |
|---|
| Open: | 0.00 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 6.96 |
|---|
| Beta: | 2.71 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.00 - 0.00 |
|---|
| 52wk Range: | 0.00 - 0.13 |
|---|
| Volume: | 427,300 |
|---|
| Avg Vol (3m): | 79,320 |
|---|
| Market Cap: | 99.63K |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.07 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- SCOLR PHARMA, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligation orEDGAR Online(Mon, Mar 4)
- SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Wed, Oct 24)
- SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibiEDGAR Online(Thu, Jun 28)
- SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial OblEDGAR Online(Fri, Jun 15)
- SCOLR PHARMA, INC. FinancialsEDGAR Online Financials(Thu, May 24)
- SCOLR PHARMA, INC. FinancialsEDGAR Online Financials(Thu, May 24)
- SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial OblEDGAR Online(Thu, May 10)
- SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial OblEDGAR Online(Thu, May 10)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.19 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-10)
: | N/A |
|---|
| Quarterly EPS Est
(Dec-10)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
SCOLR Pharma, Inc., specialty pharmaceutical company, develops and commercializes prescription, over-the-counter, and nutritional products. The company uses its controlled delivery technology platform and develops water soluble and insoluble drugs...
View More